StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Income Taxes Paid by Year

Income Taxes Paid ($M)

Novartis Income Taxes Paid: $2,562M in FY2025, up 13.5% from a year earlier.

Latest, FY2025
2,562
Period ended Dec 31, 2025
Change on a year earlier
+13.5%
2,258 in FY2024
History
11 years
Since FY2015
Sources
6
Documents cited below

Where the FY2025 figure comes from

Source: Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗

Reported in Postgres DB + Form 6-K.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Novartis Income Taxes Paid ($M), annual FY2015–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-cf-taxes-paid

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.